News

We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees

Oxford Invention Fund invests in new antibiotics

9th August 2011
All News | Financial News | Technology News

A fund designed to bridge the "innovation gap", supporting University of Oxford inventors in proof of concept and prototyping work, has reached its first close and made its first investment in a new class of antibiotics discovered in a natural product library at the University of Oxford's Department of Chemistry.

Read more

Intelligent Tissue Expanders to Revolutionise Surgery

1st August 2011
All News | Financial News | Spinouts & Startups | Technology News

Oxtex Limited, the newest spin-out from Oxford University Innovation Ltd, the technology transfer office of the University of Oxford, has secured £365,000 of seed funding to develop an intelligent hydrogel material for tissue expansion. For the first time, surgeons will be able to accurately and predictably control the direction, the timing, and rate of the material’s expansion in the body. This will significantly reduce the risk of soft tissue damage and associated complications. The level of control makes them ideal for use in delicate anatomical locations, particularly in the treatment of children.

Read more

Oxford’s Oxford University Innovation Expands in Asia

15th July 2011
All News | Technology News

Sixty leading names from the fields of technology, innovation and finance gathered at Club Lusitano, Hong Kong on Monday July 11 to mark the expansion of Oxford University Innovation Ltd. – the University of Oxford’s technology transfer arm – in Asia.

Read more

Symfo International and Oxford University Innovation Announce a Unique Turnkey Solution for Patient Reported Outcomes (PRO) Operations

29th June 2011
All News | Technology News

Isis Outcomes, a part of Oxford University Innovation Ltd, and Symfo are applying their respective areas of expertise to offer Sponsors and CRO1s a unique service that will help Drug Development/Study Managers to assess and choose the right PRO2 measure – validating and deploying PRO instruments, and ensuring that the study will meet Regulatory Authorities requirements.

Read more

Diagnostic test for a rare form of cancer developed by Oxford researchers

14th June 2011
All News | Technology News

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a disorder that causes the development of benign but often painful tumours in the skin and, in females, in the uterus. Between one in six and one in ten people affected by the disorder will go on to develop an aggressive form of kidney cancer called papillary renal cell cancer. The condition often strikes people in their 20s.

Read more

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation